SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Dave Gore's Trades That Make Sense -- Ignore unavailable to you. Want to Upgrade?


To: Dave Gore who wrote (9355)7/9/2002 12:34:15 PM
From: Dave Gore  Respond to of 16631
 
EXPOSING ANALYSTS & BROKERAGES: Keep the pressure on them!

EXPOSING GOLDMAN --- KG drops 60% after Goldman puts them on their Recommended List!

Maybe what we need to do is E-mail brokerage Presidents at Goldman and other firms and, most importantly, C.C. the SEC, DOJ, Eliot Spitzer, etc. whenever we spot stuff like this. Because let's face it, they are either manipulating or really stupid to put stocks on their Recommended List that drop by 60%!

07:43 ET King Pharms (KG) 37.99: Goldman Sachs upgrades to REC LIST from Mkt Outperform (NOTE: stock recently went to $17+).



To: Dave Gore who wrote (9355)7/9/2002 12:44:35 PM
From: Bruce A. Brotnov  Respond to of 16631
 
Dave, it looks like AKLM may have hit that low of 2.59 (I think Acu called 2 to 2.50) and looking better as it looks to a better earnings quarter. I picked up some again at $3 today just in case.

Anyone else getting back into AKLM again?

Bruce